Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating estrogen receptor positive carcinoma with 17 &agr;-dihydroequilin

Method of treating estrogen receptor positive carcinoma with 17 &agr;-dihydroequilin

US Patent 6342491 · Granted Jan 29, 2002

Estimated economic value: $637,962,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GDF-9/BMP-15 modulators for the treatment of bone disorders2010
Transgenic animal model of bone mass modulation2009
Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin2006
Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin2006
Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin2006
Method of lowering cholesterol1996
Use of LRH and LRH agonists1982
Claudogenic-interceptive nonapeptide1981